Episodios

  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis

    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
    Jul 2 2024
    Dr Aaron T Gerds from the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, discusses recent updates on available and novel treatment strategies for myelofibrosis.
    Más Menos
    1 h
  • Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences

    Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences
    May 29 2024
    Dr Andrew D Zelenetz from Memorial Sloan Kettering Cancer Center in New York City discusses recent updates on available and emerging treatment strategies for various lymphomas.
    Más Menos
    1 h y 17 m
  • Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    May 28 2024
    Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Más Menos
    34 m
  • Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma

    Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma
    May 24 2024
    Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.
    Más Menos
    42 m
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia

    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
    May 14 2024
    Drs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progress in diagnosing and treating acute myeloid leukemia over the past year, as well as practical considerations for patients with the disease.
    Más Menos
    1 h y 2 m
  • Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series

    Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
    May 2 2024
    Dr Ruben A Mesa from Wake Forest University School of Medicine in Winston-Salem, North Carolina, discusses recent updates on available and novel treatment strategies for myelofibrosis.
    Más Menos
    1 h y 1 m
  • Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria

    Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
    Apr 26 2024
    Dr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz summarize the biology of paroxysmal nocturnal hemoglobinuria, current treatment approaches, and practical considerations for patients with the disease.
    Más Menos
    1 h y 37 m
  • Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

    Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
    Apr 24 2024
    Dr Naveen Pemmaraju from The University of Texas MD Anderson Cancer Center in Houston discusses updated findings from ASH 2023 on management approaches for myelofibrosis and polycythemia vera.
    Más Menos
    1 h y 5 m